AU2002219830A1 - Methods for treating disorders of neuronal deficiency with bone marrow-derived cells - Google Patents

Methods for treating disorders of neuronal deficiency with bone marrow-derived cells

Info

Publication number
AU2002219830A1
AU2002219830A1 AU2002219830A AU1983002A AU2002219830A1 AU 2002219830 A1 AU2002219830 A1 AU 2002219830A1 AU 2002219830 A AU2002219830 A AU 2002219830A AU 1983002 A AU1983002 A AU 1983002A AU 2002219830 A1 AU2002219830 A1 AU 2002219830A1
Authority
AU
Australia
Prior art keywords
methods
bone marrow
derived cells
treating disorders
neuronal deficiency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002219830A
Inventor
Helen M Blau
Timothy R. Brazelton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of AU2002219830A1 publication Critical patent/AU2002219830A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2002219830A 2000-11-10 2001-11-13 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells Abandoned AU2002219830A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24712800P 2000-11-10 2000-11-10
US60247128 2000-11-10
PCT/US2001/043806 WO2002037968A1 (en) 2000-11-10 2001-11-13 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells

Publications (1)

Publication Number Publication Date
AU2002219830A1 true AU2002219830A1 (en) 2002-05-21

Family

ID=22933675

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002219830A Abandoned AU2002219830A1 (en) 2000-11-10 2001-11-13 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells

Country Status (3)

Country Link
US (1) US20020168350A1 (en)
AU (1) AU2002219830A1 (en)
WO (1) WO2002037968A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1453530A2 (en) * 2001-11-09 2004-09-08 Neuronova AB Method of proliferation in neurogenic regions
JP2005514926A (en) 2002-01-14 2005-05-26 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ Novel mammalian multipotent stem cells and compositions, methods for their preparation and administration
US7785601B2 (en) * 2002-12-31 2010-08-31 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors
KR101186218B1 (en) * 2009-08-21 2012-10-08 경희대학교 산학협력단 Use of EGF-like Domain Peptide of Heregulin Beta 1
CN102596225B (en) * 2009-10-14 2015-06-24 阿寇达医疗有限公司 Use of a neuregulin to treat peripheral nerve injury
US11253549B2 (en) 2014-05-23 2022-02-22 JangoBio, LLC Methods to rebalance the hypothalamic-pituitary-gonadal axis
US11439668B2 (en) 2014-05-23 2022-09-13 JangoBio, LLC Methods to differentiate stem cells into hormone-producing cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US5187193A (en) * 1988-09-12 1993-02-16 University Of Rochester Method for stimulating transplanted bone marrow cells
ES2102196T3 (en) * 1992-11-13 1997-07-16 Univ Washington PERIPHERIALIZATION OF HEMATOPOYETIC PLURIPOTENTIAL CELLS.
DE69430059T2 (en) * 1993-06-15 2002-11-14 British Biotech Pharm Release and mobilization of hematopoietic cells

Also Published As

Publication number Publication date
US20020168350A1 (en) 2002-11-14
WO2002037968A1 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
IL208191A0 (en) Compositions and methods for treating rage-associated disorders
WO2002086502A8 (en) Methods for the diagnosis and treatment of bone disorders
AUPQ302899A0 (en) Implants for the use in the treatment of aneurysmal disease
AU2003238561A1 (en) Compositions and methods for treating gynaecological disorders
AU2001269799A1 (en) Methods for treating various eye disorders
AU6910600A (en) Methods for the treatment of mental disorders
IL155433A0 (en) Treatment of t cell disorders
EP1173470A4 (en) Treatment of bone disorders with adrenomedullin or adrenomedullin agonists
AU3784999A (en) Methods for treatment of pain
AU4033900A (en) Compositions and methods for treating cell proliferation disorders
WO2003039490A9 (en) Compositions and methods for diagnosing and treating mental disorders
AU2002219830A1 (en) Methods for treating disorders of neuronal deficiency with bone marrow-derived cells
AU2002362115A1 (en) Composition and methods for treatment of neurological disorders
AU2002245204A1 (en) Methods for treating blood coagulation disorders
AU2003213105A1 (en) Methods and compositions in treating pain using diacylglycerol kinase epsilon
AU1133901A (en) Method of treating metabolic disorders
AU2001283199A1 (en) Methods and compositions for the diagnosis and treatment of brown adipose cell disorders
PL351554A1 (en) Osanetant in the treatment of mood disorders
IL162053A0 (en) Method for the treatment of bone disorders
AU2003275433A1 (en) Compositions and methods for treating pain
AU5855899A (en) Method for identifying substances for the treatment of c-jun-mediated disorders
IL125698A0 (en) Method for treatment of invasive cells
AU3753500A (en) Methods of treating fibrinogen-related disorders
AU2003297259A1 (en) Methods and compositions for treating neurological disorders
EP1425020A4 (en) Methods and compositions for treating apoptosis associated disorders